Offer - Urjas Oil for just ₹ 1 X
Ondero Met 2.5/500 Tablet is a prescription medicine that is available as a Tablet. Diabetes are some of its major therapeutic uses. Other than this, Ondero Met 2.5/500 Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Ondero Met 2.5/500 Tablet. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Ondero Met 2.5/500 Tablet include Diarrhoea, Nausea or vomiting, Headache. Some other side effects of Ondero Met 2.5/500 Tablet have been listed ahead. Usually, these side effects of Ondero Met 2.5/500 Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Ondero Met 2.5/500 Tablet's effect during pregnancy is Moderate and Safe while nursing. Further, the section on Ondero Met 2.5/500 Tablet related warnings talks about Ondero Met 2.5/500 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Pancreatitis, Vitamin B12 Deficiency must refrain from the use of Ondero Met 2.5/500 Tablet since this can cause severe adverse effects.
Besides this, Ondero Met 2.5/500 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Ondero Met 2.5/500 Tablet is not safe while driving, and is is not addictive in nature.
Ondero Met 2.5/500 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Ondero Met 2.5/500 Tablet is used -
Moderate
Common
Is the use of Ondero Met 2.5/500 Tablet safe for pregnant women?
Ondero Met can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Ondero Met right away. Take your doctor's advice before taking it again.
Is the use of Ondero Met 2.5/500 Tablet safe during breastfeeding?
Ondero Met does not show any harmful effects in lactating women.
What is the effect of Ondero Met 2.5/500 Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Ondero Met. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Ondero Met 2.5/500 Tablet on the Liver?
Ondero Met can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Ondero Met 2.5/500 Tablet on the Heart?
Information about safety of Ondero Met for heart is not available since scientific research on this is yet to be done.
Ondero Met 2.5/500 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ondero Met 2.5/500 Tablet unless your doctor advises you to do so -
Is this Ondero Met 2.5/500 Tablet habit forming or addictive?
Ondero Met 2.5/500 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ondero Met 2.5/500 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Ondero Met 2.5/500 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Ondero Met 2.5/500 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Ondero Met 2.5/500 Tablet
Information is not available on the interaction of any foods with Ondero Met 2.5/500 Tablet, due to a lack of research on this.
Interaction between Alcohol and Ondero Met 2.5/500 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Ondero Met 2.5/500 Tablet with alcohol will be.
Yes, Ondero Met is safe to use, many people have side effects at first, they usually diminish and then go away completely in a few weeks. A few people find they cannot tolerate metformin, there are other drugs but metformin is usually the first choice. It is very safe
Ondero Met should be taken with food to reduce stomach and bowel side effects, which may experience the first few weeks of treatment. Also, exercise regularly and test for sugar in your blood or urine as directed.
Ondero Met is not a known cause of alopecia (hair loss). However, the conditions treated by Ondero Met type 2 diabetes and PCOS, often list hair loss as a possible symptom.
Yes, you can take Ondero Met with a beta-blocker. People with diabetes tend to develop heart disease or stroke at an earlier age than the general population. One reason for this is that high glucose levels increase your risk of high blood pressure (hypertension). No harmful interactions are seen between them. However, a recent study suggests that beta-blockers can decrease the plasma level of Ondero Met and long-term use can increase lactic acid and uric acid in the blood.
Yes, Ondero Met can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with metformin. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia, always keep glucose-rich food with you.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 776
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tradjenta™ (linagliptin)
Highlights of Prescribing Information [Internet]: Jentadueto™ (linagliptin and metformin hydrochloride) tablets . Initial U.S. Approval: 2012